Nutex Health (NUTX) Cash & Current Investments (2010 - 2026)

Nutex Health has reported Cash & Current Investments for 17 years, with the latest figure at $210.6 million in Q1 2026.

• Quarterly Cash & Current Investments rose 140.26% year-over-year to $210.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $210.6 million (up 140.26% YoY) and the FY2025 annual result came in at $185.9 million, up 326.5% from the prior year.
• Cash & Current Investments improved to $210.6 million in Q1 2026 per NUTX's latest filing, from $185.9 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $210.6 million in Q1 2026 and troughed at $12.7 million in Q1 2022.
• A 5-year average of $67.9 million and a median of $40.8 million in 2024 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2023 and 2025: Cash & Current Investments slumped 35.77% in 2023, then jumped 326.5% in 2025.
• Over 5 years, Cash & Current Investments stood at $34.3 million in 2022, then slumped by 35.77% to $22.0 million in 2023, then jumped by 98.08% to $43.6 million in 2024, then jumped by 326.5% to $185.9 million in 2025, then rose by 13.33% to $210.6 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $210.6 million, $185.9 million, and $166.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.